Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 13;2015(11):CD010169.
doi: 10.1002/14651858.CD010169.pub2.

Treatment for dysphagia (swallowing difficulties) in hereditary ataxia

Adam P Vogel  1 , Megan J Keage, Kerstin Johansson, Ellika Schalling
Affiliations

Treatment for dysphagia (swallowing difficulties) in hereditary ataxia

Adam P Vogel et al. Cochrane Database Syst Rev. .

Abstract

Background: Hereditary ataxias are a heterogeneous group of disorders resulting in progressive inco-ordination. Swallowing impairment, also known as dysphagia, is a common and potentially life threatening sequel of disease progression. The incidence and nature of dysphagia in these conditions is largely unknown. The loss of an effective and safe swallow can dramatically affect the health and well-being of an individual. Remediation of difficulties of eating and drinking is an important goal in the clinical care of people with hereditary ataxia.

Objectives: To assess the effects of interventions for swallowing impairment (dysphagia) in people with hereditary ataxias.

Search methods: We searched the Cochrane Neuromuscular Disease Group Specialized Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL Plus, PsycINFO, and the Education Resources Information Center (ERIC) on 14 September 2015. We also searched Linguistics and Language Behavior Abstracts (LLBA), Dissertation Abstracts, and Trials Registries on 24 September 2015.

Selection criteria: We considered all randomised controlled trials (RCTs) and quasi-RCTs that compared treatments for hereditary ataxia with placebo or no treatment. We only included studies measuring dysphagia.

Data collection and analysis: Three review authors (ES, KJ, MK) independently screened all titles and abstracts. In the event of any disagreement or uncertainty over the inclusion of a particular paper, the review authors planned to meet and reach consensus.

Main results: We identified no RCTs from the 519 titles and abstracts screened. We excluded papers primarily for not including participants with a hereditary ataxia (that is, being focused on other neurological conditions), being theoretical reviews rather than intervention studies, or being neither randomised nor quasi-randomised trials.We identified five papers of various design that described treatment for dysphagia, or improvement to swallow as a by-product of treatment, in people with hereditary ataxia. None of these studies were RCTs or quasi-RCTs.

Authors' conclusions: There is an absence of any significant evidence supporting the use of any dysphagia intervention in hereditary ataxia. The lack of evidence highlights the critical need for well-controlled treatment trials in the field.

PubMed Disclaimer

Conflict of interest statement

None of the four authors has a conflict of interest.

Figures

1
1
Flow diagram of the study selection process. RCT: randomised controlled trial
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD010169

References

References to studies excluded from this review

Alfonsi 2010 {published data only}
    1. Alfonsi E, Merlo IM, Ponzio M, Montomoli C, Tassorelli C, Biancardi C, et al. An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment. Journal of Neurology, Neurosurgery & Psychiatry 2010;81(1):54‐60. - PubMed
Freund 2007 {published data only}
    1. Freund HJ, Barnikol UB, Nolte D, Treuer H, Auburger G, Tass PA, et al. Subthalamic‐thalamic DBS in a case with spinocerebellar ataxia type 2 and severe tremor ‐ a unusual clinical benefit. Movement Disorders 2007;22(5):732‐5. - PubMed
Lefton‐Greif 2011 {published data only}
    1. Lefton‐Greif MA, Crawford TO, McGrath‐Morrow S, Carson KA, Lederman HM. Safety and caregiver satisfaction with gastrostomy in patients with ataxia telangiectasia. Orphanet Journal of Rare Diseases 2011;6:23. [DOI: 10.1186/1750-1172-6-23] - DOI - PMC - PubMed
Powell 2007 {published data only}
    1. Barlow JH, Cullen‐Powell LA, Williams H. The training & support programme for parents of children with ataxia: a pilot study. Psychology, Health & Medicine 2007;12(1):64‐9. [DOI: 10.1080/13548500600580931] - DOI - PubMed
Wraith 2009 {published data only}
    1. Wraith JE, Imrie J. New therapies in the management of Niemann‐Pick type C disease: clinical utility of miglustat. Therapeutics and Clinical Risk Management 2009;5(1):877‐87. - PMC - PubMed

Additional references

Bath 1999
    1. Bath PM, Bath‐Hextall FJ, Smithard D. Interventions for dysphagia in acute stroke. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD000323] - DOI - PubMed
Belafsky 2008
    1. Belafsky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Allen J, et al. Validity and reliability of the Eating Assessment Tool (EAT‐10). Annals of Otology, Rhinology and Laryngology 2008;117(12):919‐24. - PubMed
Bilney 2003
    1. Bilney B, Morris ME, Perry A. Effectiveness of physiotherapy, occupational therapy, and speech pathology for people with Huntington's disease: a systematic review. Neurorehabilitation and Neural Repair 2003;17(1):12‐24. - PubMed
Cancel 1997
    1. Cancel G, Dürr A, Didierjean O, Imbert G, Bürk K, Lezin A, et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Human Molecular Genetics 1997;6(5):709‐15. - PubMed
Corben 2014
    1. Corben LA, Lynch D, Pandolfo M, Schulz JB, Delatycki MB. Clinical Management Guidelines Writing Group. Consensus clinical management guidelines for Friedreich ataxia. Orphanet Journal of Rare Diseases 2014;9:184. [DOI: 10.1186/s13023-014-0184-7] - DOI - PMC - PubMed
Cossée 1997
    1. Cossée M, Schmitt M, Campuzano V, Reutenauer L, Moutou C, Mandel J‐L, et al. Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proceedings of the National Academy of Sciences of the United States of America 1997;94(14):7452‐7. - PMC - PubMed
David 1998
    1. David G, Dürr A, Stevanin G, Cancel G, Abbas N, Benomar A, et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Human Molecular Genetics 1998;7(2):165‐70. - PubMed
Davis 2000
    1. Davis EC, Barnes MP. Botulinum toxin and spasticity. Journal of Neurology, Neurosurgery and Psychiatry 2000;69(2):143‐7. - PMC - PubMed
Deane 2001
    1. Deane KH, Whurr R, Clarke CE, Playford ED, Ben‐Shlomo Y. Non‐pharmacological therapies for dysphagia in Parkinson's disease. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD002816] - DOI - PMC - PubMed
Dressler 2010
    1. Dressler D. Botulinum toxin for treatment of dystonia. European Journal of Neurology 2010;17 Suppl 1:88‐96. - PubMed
Dürr 1996
    1. Dürr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, et al. Spinocerebellar ataxia 3 and Machado‐Joseph disease: clinical, molecular, and neuropathological features. Annals of Neurology 1996;39(4):490‐9. - PubMed
Dürr 2010
    1. Dürr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurology 2010;9(9):885‐94. - PubMed
Ekberg 2002
    1. Ekberg O, Hamdy S, Woisard V, Wuttge‐Hannig A, Ortega P. Social and psychological burden of dysphagia: its Impact on diagnosis and treatment. Dysphagia 2002;17(2):139‐46. - PubMed
Epplen 1997
    1. Epplen C, Epplen JT, Frank G, Miterski B, Santos EJ, Schöls L. Differential stability of the (GAA)n tract in the Friedreich ataxia (STM7) gene. Human Genetics 1997;99(6):834‐6. - PubMed
Erichsen 2009
    1. Erichsen AK, Koht J, Stray‐Pedersen A, Abdelnoor M, Tallaksen CM. Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population‐based study. Brain 2009;132(Pt 6):1577‐88. - PubMed
Genis 1995
    1. Genis D, Matilla T, Volpini V, Rosell J, Davalos A, Ferrer I, et al. Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptoms. Neurology 1995;45(1):24‐30. - PubMed
Gomes 2015
    1. Gomes Jr CAR, Andriolo RB, Bennett C, Lustosa SAS, Matos D, Waisberg DR, et al. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances. Cochrane Database of Systematic Reviews 2015, Issue 5. [DOI: 10.1002/14651858.CD008096.pub4] - DOI - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hill 2004
    1. Hill M, Hughes T, Milford C. Treatment for swallowing difficulties (dysphagia) in chronic muscle disease. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD004303.pub2] - DOI - PubMed
Jardim 2001
    1. Jardim LB, Pereira ML, Silveira I, Ferro A, Sequeiros J, Giugliani R. Neurologic findings in Machado‐Joseph disease: relation with disease duration, subtypes, and (CAG)n. Archives of Neurology 2001;58(6):899‐904. - PubMed
Johansson 1998
    1. Johansson J, Forsgren L, Sandgren O, Brice A, Holmgren G, Holmberg M. Expanded CAG repeats in Swedish spinocerebellar ataxia Type 7 (SCA7) patients: effect of CAG repeat length on the clinical manifestation. Human Molecular Genetics 1998;7(2):171‐6. - PubMed
Jones 2015
    1. Jones K, Pitceathly RDS, Rose MR, McGowan S, Hill M, Badrising UA, et al. Interventions for dysphagia in long‐term, progressive muscle disease. Cochrane Database of Systematic Reviews 2015, Issue (in press). - PMC - PubMed
Klockgether 2011
    1. Klockgether T, Paulson H. Milestones in ataxia. Movement Disorders 2011;26(6):1134‐41. - PMC - PubMed
Logemann 2008
    1. Logemann JA, Gensler G, Robbins J, Lindblad AS, Brandt D, Hind JA. A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson's disease. Journal of Speech, Language, and Hearing Research 2008;51(1):173‐83. - PMC - PubMed
McCulloch 1996
    1. McCulloch TM, Perlman AL, Palmer PM, Daele DJ. Laryngeal activity during swallow, phonation, and the Valsalva maneuver: an electromyographic analysis. Laryngoscope 1996;106(11):1351‐8. - PubMed
McHorney 2006
    1. McHorney C, Martin‐Harris B, Robbins J, Rosenbek J. Clinical validity of the SWAL‐QOL and SWAL‐CARE outcome tools with respect to bolus flow measures. Dysphagia 2006;21(3):141‐8. - PubMed
Morgan 2012
    1. Morgan AT, Dodrill P, Ward EC. Interventions for oropharyngeal dysphagia in children with neurological impairment. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD009456.pub2] - DOI - PMC - PubMed
Pandolfo 2009
    1. Pandolfo M. Friedreich ataxia: the clinical picture. Journal of Neurology 2009;256 Suppl 1:3‐8. - PubMed
Paulson 2009
    1. Paulson HL. The spinocerebellar ataxias. Journal of Neuro‐Ophthalmology 2009;29(3):227‐37. - PMC - PubMed
Regan 2014
    1. Regan J, Murphy A, Chiang M, McMahon BP, Coughlan T, Walshe M. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders. Cochrane Database of Systematic Reviews 2014, Issue 5. [DOI: 10.1002/14651858.CD009968.pub2] - DOI - PMC - PubMed
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Rolfs 2003
    1. Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, Topka H, et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Annals of Neurology 2003;54(3):367‐75. - PubMed
Rosenbek 1996
    1. Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration‐aspiration scale. Dysphagia 1996;11(2):93‐8. - PubMed
Rüb 2004
    1. Rüb U, Bürk K, Schöls L, Brunt ER, Vos RA, Diaz GO, et al. Damage to the reticulotegmental nucleus of the pons in spinocerebellar ataxia type 1, 2, and 3. Neurology 2004;63(7):1258‐63. - PubMed
Rüb 2012
    1. Rüb U, Bürk K, Timmann D, Dunnen W, Seidel K, Farrag K, et al. Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico‐pathological insights. Neuropathology and Applied Neurobiology 2012;38(7):665‐80. [DOI: 10.1111/j.1365-2990.2012.01259] - DOI - PubMed
Schapiro 2002
    1. Schapiro RT. Pharmacologic options for the management of multiple sclerosis symptoms. Neurorehabilitation and Neural Repair 2002;16(3):223‐31. - PubMed
Schulz 2009
    1. Schulz JB, Boesch S, Bürk K, Dürr A, Giunti P, Mariotti C, et al. Diagnosis and treatment of Friedreich ataxia: a European perspective. Nature Reviews Neurology 2009;5(4):222‐34. - PubMed
Schöls 1998
    1. Schöls L, Krüger R, Amoiridis G, Przuntek H, Epplen JT, Riess O. Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds. Journal of Neurology, Neurosurgery and Psychiatry 1998;64(1):67‐73. - PMC - PubMed
Sciortino 2003
    1. Sciortino KF, Liss JM, Case JL, Gerritsen KGM, Katz RC. Effects of mechanical, cold, gustatory, and combined stimulation to the human anterior faucial pillars. Dysphagia 2003;18(1):16‐26. - PubMed
Takahashi 2004
    1. Takahashi H, Ishikawa K, Tsutsumi T, Fujigasaki H, Kawata A, Okiyama R, et al. A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6. Journal of Human Genetics 2004;49(5):256‐64. [DOI: 10.1007/s10038-004-0142-7] - DOI - PubMed
Vogel 2014a
    1. Vogel AP, Brown SE, Folker JE, Corben LA, Delatycki MB. Dysphagia and swallowing‐related quality of life in Friedreich ataxia. Journal of Neurology 2014;261(2):392‐9. [DOI: 10.1007/s00415-013-7208-4] - DOI - PubMed
Vogel 2014b
    1. Vogel AP, Folker JE, Poole ML. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD008953] - DOI - PMC - PubMed
Vogel 2015
    1. Vogel AP, Fendel L, Brubacher KP, Chan V, Maule R. Dysphagia in spinocerebellar ataxia and multiple system atrophy‐cerebellar. Speech, Language and Hearing 2015;18(1):39‐43. [DOI: 10.1179/2050572814Y.0000000047] - DOI
Ware 1992
    1. Ware JE Jr, Sherbourne CD. The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Medical Care 1992;30(6):473‐83. - PubMed
Welch 1993
    1. Welch MV, Logemann JA, Rademaker AW, Kahrilas PJ. Changes in pharyngeal dimensions effected by chin tuck. Archives of Physical and Medical Rehabilitation 1993;74(2):178‐81. - PubMed
Whaley 2011
    1. Whaley NR, Fujioka S, Wszolek ZK. Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics. Orphanet Journal of Rare Diseases 2011;6:33. - PMC - PubMed

Publication types

MeSH terms